chemXplore tracks 22 projects in Denmark, of which 5 are active.
Of the active ones, 3 new construction and 2 expansion.
2 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
Projects in Europe and the US illustrate local hydrogen supply for refining, e-fuels and freight, as well as fuel cells used to ease grid constraints.
Capture, transport, utilisation and storage can help address emissions from sectors such as cement and steel, alongside clean energy and efficiency measures.
Quarterly net cash use fell 54% sequentially to $28m, while operating expenses dropped 69% year on year.
Extension runs to June 2028 for access, inspection, NDT and rope-access services across Danish North Sea platforms; 510,000+ offshore hours logged with zero lost time incidents.
EU clears first PD‑1 inhibitor plus ADC regimen for resectable muscle‑invasive bladder cancer regardless of cisplatin eligibility; phase 3 showed EFS HR 0.53 and OS HR 0.65.
Converts excess shore crabs via chemical-free mechanical/thermal separation into aquafeed and pet-food proteins and shell-derived chitosan; pilot 2 t/day, target 40,000 t/yr.
Q3 revenue rose >10% y/y and company remains on track for ~15–16% full‑year growth; Q3 net cash usage ≈ $28M with ≈ $134M cash on hand; margin improvement and an ~$8bn electrolyzer pipeline.
Selected for a six‑month incubation to test a modular carbon capture unit designed for space‑constrained data centre power plants.
Rina‑S 120 mg/m² Q3W achieved 45.9% ORR and 12.1‑month median DOR in 109 platinum‑resistant ovarian cancer patients; activity seen across FRα expression levels.
Preferred electrolyzer supplier for over 1 GW of e‑SAF projects; initial 280 MW GenEco will produce ~110 t/day renewable H2 for jet fuel at Port of Vordingborg; ENDOR moving to FID.